Qualicorp Consultoria e Corretora de Seguros SA
BOVESPA:QUAL3
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.35
3.41
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Ladies and gentlemen, and thank you for holding. Welcome to Quali's conference call to discuss the results for the fourth quarter '23.
Present with us today are Mr. Mauricio Lopes, the company's CEO; Carlos Vasques, Investor Relations Officer and CFO; and Mr. Eduardo Garcia, Investor Relations Superintendent.
Bear in mind that some statements in this webcast may be forward-looking statements. Such statements are subject to known and unknown risks and uncertainties that may cause such expectations not to be fulfilled or differ materially from what was expected.
This event is being broadcast simultaneously, [Operator Instructions]
I would now like to give the floor over to Mr. Mauricio Lopes who will begin the presentation.
Good morning, everybody. It's a pleasure to speak to you today, analysts, investors and colleagues that follow up on this conference and make things happen. I would like to highlight that we haven't had any change in the dynamic of the sector nor change in the plans [ set for ] in previous quarters, the planning was done. The turnaround has been structured, and we continue to execute the planning presented to the Board of Management very diligently.
We have a focus on capital allocation, whether it is debt, cash allocation, CAC allocation. We're testing the validity of CAC, in the retail market, there is more compression. And we try to understand the point of balance of the CAC vis-a-vis the products we have to sell.
Along with this, we're seeking a new level of internal efficiency to have a company giving us more results.
After the restructuring, we have carried out a rightsizing in the company, and we are now working based on science to understand the pockets of profitability we have now reached. And we're also designing a product portfolio.
Quali has the best sector in the market in SME and with our existing products, although we still think the portfolio is below what we will have in the future.
If we look at the dynamic of the sector as a whole, we still suffer pressure because of the product, the difficulty in cash and so on and so forth. But in this scenario, we have been able to have new possibilities of products, new possibilities for operators that are less incumbent, and this can enhance our sales performance.
This is the portrait of retail going through a very strong restructuring and Quali is the company with the greatest resilience in this sector. We remind you that the retail structure sustains most of the operators but we do want to have a very good portfolio with more than 100 operators and more than 400 entities that we work with in this structure.
We are convinced that we are the protagonists of the restructuring of the sector, the restructuring of the retail market, and we're going to lead the changes that are necessary to favor the sector.
I would now like to give the floor to Carlos Vasques to speak about the results, and I am at your disposal for questions at the end.
Well, thank you, Mauricio. Good morning, everybody. I'm going to refer to the figures in the company, what we attained in the fourth quarter.
Now the company reported total net revenues of BRL 414 million in the fourth quarter, a reduction of 6.6% quarter-on-quarter due to a reduction of the Affinity portfolio, with a reduction of 6.9% in the quarter, ending the year with 785,000 beneficiaries. Now we had 2,000,103 clients in the portfolio, a drop of 21.7%. Year-on-year, we began with 1,005,000 clients in the portfolio.
But what is important to say is that thanks to the sale of 245,000 lives and a churn of 462.9 lives, a churn of 50%, which is still quite high considering the normalized market rate.
Now the net revenue totaled [ BRL 1,749.9 billion ], a reduction of 10% year-on-year because of the customer base with a reduction of 21.7%, partially offset by the increases of price readjustments during the year.
Now to speak about costs and expenses. The company in the fourth quarter had expenses totaling BRL 244.7 million but that represents 0.6% increase quarter-on-quarter. And if we look at the accrued figure, minus 5.1% year-on-year. If we look at quarter-on-quarter, we already observed a reduction of 12%.
Fixed expenses totaled BRL 138.2 million, when we analyze that table below and observe the cost the package of costs, we can see a reduction very clearly, 12% year-on-year. And we believe that in the coming quarters, that trend will continue on because of all of the activities that are being carried out in the company.
We remind you that this doesn't pertain necessarily to the fourth quarter. We're going to look at all of the impacts because the actions began in the second half of the year of 2023.
We look at variable cost, totaling BRL 106.5 million in the fourth quarter, consuming 25.6% of revenues on our recurrent base, 23.7%. Now this is from that involves the new models that are being set in place and discuss with the partners throughout the period. It's a redesign of what should be done, therefore, we have several conversations with the channels, with [ co-entities ], with the brokers, and this is a front that is underway, and it is a point of attention for the company management. We do hope to have good behavior here throughout 2024, that front of variable expenses.
As part of variable expenses we have the [indiscernible]. And what I would like to highlight here 2 events in the quarter, one event relating -- well, that we decided was a one-off event due to a migration of systems for the invoicing of the company where the management adopted the necessary measures for situations such as that one, partially migrating the systems-only part of the company to begin the turnaround. And this has been done gradually compared to other strategies that could increase the risk in the operation.
We carried out that migration last year, we did face challenges. And that is why we have that provision highlighted as being nonrecurrent and representing BRL 30 million.
In the second effect that you can see on the graph, the BRL 106.5 million. This refers to the BRL 8 million that originates from the review of clients in the Gama Group. We had already seen a very high credit risk. Therefore, we decided to interrupt some services to have a healthier credit conditions through the coming quarters.
If we look at the company EBITDA, the company posted an adjusted EBITDA of BRL 169.7 with a 40.9% margin. That still is not the standard that we desire. We're heading towards our standard. Notwithstanding this, the efficiency strategy of operational cost as well as discipline in capital allocation have enabled us to generate a CAC EBITDA of BRL 137 million with a 33% margin, which is a much healthier margin.
Now the performance quarter-on-quarter reflects the base. And we hope that throughout the period, this will be regauging the investments in the different channels, enabling us to grow in a sustainable fashion.
Just now look at our effective cash generation in the company. The company ended the quarter with BRL 109.4 million of free cash flow. This is the cash flow before amortization, before taxes and before dividend. I would like to highlight that in that quarter we paid the interest rate of debentures amounting to BRL 511 million. These are interest rates paid every half of the year.
Now, if we look at the accrued figures, we see a company that generated BRL 511 million for the year, now this BRL 511 million were used to pay BRL 235 million in expenses for net interest rate from the financial expenses. This ended up with a final generation of BRL 576 million, enabling us to continue on with our strategy of readjusting our capital structure, ensuring that the net debt of the company could end at BRL 1.220 million.
I would like to add here that we had a material fact in the last few days for a new fundraising carried out by the company of BRL 200 million. This is part of the program for the reduction of debt that is underway, and we believe that this will reinforce the company liquid. It is significantly so that we can have security during this process of implementing the turnaround plan that we have been discussing with you broadly.
Now with this, we would like to end the main highlights of the financial part, and we would now like to open the floor for questions and answer.
[Operator Instructions] Our first question comes from the BTG Pactual, [ Juan ].
I have 2 questions at my end. The first refers to dividend which is the outlook for the payout in 2024, and if you're expecting a payout with your minimum levels of 25% of -- or if you're thinking about something different?
And the second question is about your budget plan. Has it been approved at the Board already? And if you could give us more color in terms of your budget, if it contemplates a stable base of members during the year or any other comments that you may add?
I'm going to begin here speaking about dividends. The dividend were paid in the fourth quarter, representing BRL 23 million approximately now. These dividends come from 2022, and they refer to the minimum mandatory dividend. They were part of our balance since last year and management has the obligation to comply with the minimum mandatory dividends. We carried out the payment in December.
Now looking forward to 2024, and for this, we have to look at the accounting results of 2023. Due to the restructuring cost through time, all of the plans that we have put in place here, this created an accounting [ loans ]. We will not have any provision of dividends for 2024, precisely because of these restructuring costs.
Now our vision in the midterm is that the company will be profitable, will be lucrative, it will continue on with its restructuring and reduction of leverage and comply with the minimum mandatory dividend payout. We believe that beginning in 2025, the company will once again resume the payout of dividends. And of course, we -- once we have results, we will go back to the mandatory minimum dividends. We need to be sustainable in the medium and long-term.
When it comes to the second question. The stabilization of the base. I'll tell you what we're looking at, Juan, the base stabilization goes through some drivers. One is what you're doing with your operators and this connects directly with the churn, our capacity to sell our products, and the third is the macroeconomic situation of the country.
Now in terms of the magnitude of the readjustment applied, it is our perception that the situation is somewhat better than it was last year. In January and February, we have a more balanced readjustment with a lower pressure on churn. We're going to see the readjustment of July. And we'll see if the market is somewhat more balanced. We need to follow up on this. We still don't have a response on this.
Regarding sales, as I said, we're testing the resilience of the CAC, to see which is the point of balance, our internal reading is that the CAC is lower than it should be and that is why we're investing more here. If we have a response from sales we will find a better point of balance, for some reason, we don't attain this. We will have to work with a lower CAC without major problems.
And finally, the macro situation, the capacity of payment of families in Affinity or individual plants rather imprecise. We have the internal perception that these 3 elements that we're working with the CAC readjustment with operators and products are being well worked on. And of course, macro is imprecise. We don't have guidance, but if we could speak about which are the 3 areas we're working on. It is the current, and the third one, we don't control.
Our next question comes from Fred Mendes from Bank of America.
I have 2 questions here. The first refers to strategy -- it has been 7 months that the new management came in for the turnaround. I would like to understand your mindset about the status of the turnaround, are you at the beginning, in the middle or coming close to the end, and along those same lines, where do you see that Qualicorp will head for in the next 2 years? Will it be a company with more SMEs? With more Affinity plan? This is the first question.
My second question is for Vasques. Referring to the debt market. You recently have worked with debentures of BRL 200 million secondary market. If you could give us an updated review and if it's necessary to issue more debentures, how do you consider this market for Quali?
This is Mauricio, Fred. Thank you for the question. Fred, what is it that we decided when the new management entered the company, we were going to focus on the fundamentals of the house of back to basics. And then this back to basic, the first thing we looked at was debt, how to restructure this or stabilize the capital structure of the company, paying out debt and much more.
The faster solution was to work with the rightsizing in-house to have cost more adherent to what the company sees in the outside market. And I think this has been done, if we think about the internal structure and the structure of our suppliers. Now obviously, we can't do a rightsizing in 1 month and resolve everything in a month.
Well, we can show you and the fixed prices give us a good vision of this. This will improve in the coming months as we grew our gains. We have been able to work with a significant compression that will generate cash and generate results. Of course, there is much more going on. But this was a way of beginning the actions and to take them to giving us results, and that has been done.
Now when we speak about the debt and with this issuance that we carried out last week, to have an efficient capital structure, the sales dynamic doesn't matter, the dynamic of the market doesn't matter, what is important is to have tranquility to be able to navigate through this. So I check the box. This has been done.
What we have been working strongly on is how to generate internal efficiency. One thing is to work with the rightsizing. Another thing is to gain efficiency, to have a better look at our products, and we have been working on this during the last 2 or 3 months, we think we will have positive results. The time to launch a product must be much faster, not 3 or 4 months. The time to train and develop the sales force and commercial partners should not be a long period. It should be done in 30 days.
But in the meantime, we were restructuring the commercial model of the channel. We did this in December and January. We rolled out a new brokerage contract to all of our brokers, aligned with the practices that we want to see in the long-term in agreement with operators. We are requesting assertiveness in the sale, a very early churn. Sales that focus on the clients with a better claim, with a better price product which means a client that potentially could have a bias in the sales done and where they should have a temporary coverage according to the legislation. We have been able to roll all of this until the end of January.
So this is where we're at, generating efficiency for the company and realigning the commercial channel. There is a third moment that will begin in some months which is when we will begin to see the results of our new product portfolio. The market is under greater stress than we would like it to have, this covers the entire sector. The market, therefore, is in a situation of stress, and it's always more difficult to hold the discussions of having lower prices at different pricing or a market with different possibilities. And this brings ever more complexity to our work.
Now when we look at our product portfolio and the product portfolio of competition, our SME portfolio is quite full, we have all the right operators. And in the Affinity portfolio, we have 2 or 3 players offering us better prices. We had 15% of average discount, something that began on March 1, and this, of course, will bring about significant changes we're seeking exclusivity that is important in distribution.
We will have a better control of [indiscernible] and the quality of what is being sold. We will have a channel that is more aligned with the company in terms of what operators are seeking. And this, I believe, is the third phase that is still incipient but should roll out in the coming months.
Now regarding the future, well, we see going forward, we're going to redesign the retail segment. It has always been the segment giving operators the most profitability. It could be scarce in terms of cash, it generates less cash, but generates long-term profitability. This is not something that we saw in previous quarters. So we have to increase the share of SMEs, perhaps individual plans, we're removing the SME for 2 lives in our portfolio because of the complexity and operators have understood this the right place for these clients is in an Affinity portfolio or individual portfolio.
A large operator has already withdrawn these products from their portfolio. So we will have a capacity of distribution in the retail market. We can distribute everything.
And when we look at the take rate of these products, they're all very equivalent. It includes the management spread and much more. So we're in the right position to market all these products, and we're working with the commercial channels and distribution channels to understand this. This is not something that happens overnight, but I think we will have a more balanced company in the midterm.
In the retail sector as a whole, with a focus on Affinity also greater protagonism for SME and products where we have greater exclusivity. It's work in progress, in the full sense of this world.
If I haven't addressed your question, Fred, please feel free to ask a follow-up question.
No, that was very clear, Mauricio, as always, I don't know if Vasques could refer to the debt market.
Yes, Fred, I have the question here. The company, Fred, played a significant role in the market. We have a debt that totalizes BRL 2.200 billion and 100% of our fundraising is devoted to the channel. We saw that, that channel was undergoing greater stress. We did not agree with the interpretation that was taking place in that type of funding, and that is why we have thought out funding diversity. We have spoken to our banking partners who follow up on our business, and we have opened up this new front. And this new front, therefore, will become -- will be taken out by one of our partners. We're coming closer to the banking sector to convey a message of security to the capital market.
Our process of conversing with the partners has had a higher demand than this volume because we're discussing [ rights ], but we can't see the liquidity. We don't identify problems of liquidity in the transaction. And this operation gives us the comfort that we will have a very low risk of having to roll the debt in the next 2.5 years.
So the company, therefore, is doing what it used to do in the past, which is to diversify its sources, 100% of the debt was linked to the capital market. We're now working with the banking market. And we think that this operation, given the circumstances, will be better and at a cost that for the time being, would allow us to work with this.
But -- once again, we have returned to working with the banking market to diversify because in the capital market, the prices were somewhat restrictive. Once again, the company has liquidity that has been fully reestablished after the cash generation of BRL 275 million, free cash flow at the end of last year plus this fundraising.
We diversified our channels, and we're going to continue along these lines. We might take out other channels. And this is a win-win situation for everybody. We will have the banking market, the capital market as well as other fronts that we are conversing with. So we believe that this will enable us to have a better sound situation when conversing with the capital market.
Our next question comes from Gustavo Miele from Goldman Sachs.
We have 2 questions. The first focused on results, perhaps for Vasques. Let's go back to the provisions that you explored in the presentation. When you adjust those nonrecurring effects of BRL 31 million, we still see those provisions representing 8% of the revenues. It seems to be the highest in the company since the fourth quarter of '21. Unless I am mistaken, is there seasonality in this process?
When we look backwards, it seems the fourth quarters have higher volumes than other quarters, perhaps this is due to the higher readjustment, the concentrate in the third quarter? Or has there been another event that you could highlight in this more recurrent provision that we see in the fourth quarter?
And the second question for Mauricio, is a follow-up on a comment he made in the previous question. The duality of the SME and Affinity products. This is one of the discussion we have with the investors, that the placement of the risk and how the category of products seem to be somewhat peculiar when we look at your historical average.
So from Mauricio, what is happening with your conversations with operators for the new price of SME products and the individual plans, as you mentioned in the previous question. If you could give us more details, that would be wonderful.
I'm going to begin speaking about the -- well, the question is [ pertaining to ] -- seasonally, the fourth quarter does have higher provisions because of the interest rate adjustments, and this has an impact at the end of the year and at the beginning of the year, seasonally, we are stronger in terms of default. Now the largest effect here is the recurrence. Now that has to continue to be analyzed, and we have highlighted the one-off events so that this would not hamper your understanding of the business.
The cleanup of Gama, we looked at the portfolio. We had 2 or 3 small operators that had a very high credit risk. The risk was materializing, and therefore, we decided to restructure that portfolio.
Now secondly, one of event that may not have happened in the migration of the system among all of the playbook, we chose a regional company, a small one and expand the system transition vis-a-vis a model that would not place the company at risk. So this represents less than 5% of the total revenue of the group, but we did get problems with invoicing.
Once again, this was a one-off effect, and now that we understand that we think there will be more of that seasonal effect and not that one-off effect that was caused by Gama impacting the invoicing of the company now. We should always recall the seasonal effect at the end of the year.
Now if we look at the second point, SME versus Affinity, the structure of distribution of SME in the last few years will lead to difficulties in the risk pool through time. Operators have brought into this risk pool. Well, you know that there is a geographic breadth of the product, whatever the readjustment will be the same. And we have focused on structures that are completely asymmetrical, and this, of course, is not sustainable. And we have been very focused on this agenda with operators.
We have 2 jobs here, technical convincing, which is easier. The discussion is quite simple. If it's not dogmatic and the second more complex part, after the technical convincement, how to alter the route of the operator structure? How can the operator delever from this small company and move to Affinity, which is the right place where the contracts of 3, 4 live should be.
It's not a simple task to hold this discussion, but it has proven to have put better reality during the last few months. We have a large operator that in January or February, if I'm not mistaken, suspended the SME for 2 live, and there will be followers, 3 to 4 lives will be taken off the shelves in the coming months because this is the right thing to do, if Affinity shows a good sales performance.
And it's not just about selling it, selling in alignment with what the operator and the client want to see, a sustainable portfolio, a sound risk assessment that will allow for a mutual agreement, not working with highly adverse risk.
Now the better this design, the faster, we can move to Affinity in detriment of SME, and we're at this point in our journey, and day and night, we offer arguments to operators to convince them. I'm convinced that this will work. But of course, we still have a few months this to happen, and we deploy a great deal of energy to this. And we will maintain you updated in terms of the type of product we'll work with.
Our next question come from Leandro Bastos from Citi.
We have only 2 questions. First, to speak about products, the remodeling that you are posturing. If you could comment today on the main drivers of your portfolio of products, if you're thinking of co-participation or reimbursement, and you said that this is work in progress. So what do you foresee in terms of product design? That is the first question.
The second question which is your evolution of claims, not only in your portfolio, but for the market as a whole and your partners as well, if you could test the temperature of what is happening there?
Two excellent questions, because they explain the short and medium-term trend, which are the 2 most important points of the structure and the restructuring of the retail segment. This product model at present, with a very broad network, high reimbursements and without co-participation will not be for the long-term for the retail segment. The retail segment cannot deal with this. We will have this in large corporate contracts where we have that mutuality in the contract, that's where we will find this.
It will set aside the retail market for great profit. This was not the case in the past. Well, perhaps it was there in the past. These fundamentals were forgotten, everything was put in the same bag, the retail market and larger groups. And now the time has come to work with a separation once again. Now large operators have co-participation. They have a very low level of reimbursement. But we see still some mix networks and we see very little attention on very broad products.
What have we done so we can work with the operator? We have changed the invoicing of co-participation, which is something that has become ever more prevalent. It did not exist in the past. We believe that we want higher added value for the network. So this will attract the client more. And so the system can be more sustainable.
Hospital products, for example, that are very difficult to sell. We're working with specific campaign to work with these. They have a very low claim level, and they help sell the portfolio.
When we look at the operators in our portfolio that have well-calibrated products, we see more interesting claim levels or the operators on the other hand that have lagged behind in the launch of new portfolios, more aligned with the market needs have shown to have higher claim levels.
So we can work with installments in the contract or have readjustments that are higher than we would like to have. And we have managed this situation as best as possible. We have reinforced the retention team. The retention team has been fully redesigned by the Board of Quali, a senior Board with a very long experience in this, and we have changed the structure. The structure is robust, discipline that has been trained, and we're working with models where the client has been submitted to readjustments that are higher, and that's why we're creating something more sustainable in the new portfolio and with all stakeholders, whether they are entities, brokers, platform, we have redesigned the incentive system.
Well, we are preparing our readjustment of portfolios after 12 or 24 months and so on. We did not work with this. We would work with higher rates at the entry and then work with readjustments through the life of the portfolio. Now this is not a good direction for those who want to have a permanent portfolio. So we're working with different commissions after the first readjustment, after the second readjustment and so on, successively, which should increase the lifespan of the product. This will help us in terms of permanence, and it is well aligned with what operators want.
Now we have had a quick reduction in claims throughout this year because of this, for those who have done their homework, and this will be the future of the retail segment. And this is what we have to focus on in product portfolio.
Our next question come from Felipe Amancio from Itau BBA.
The first question was already asked by our colleagues. If you could remark on your mix compared to previous years, do you think that the vertical products continue to be important or not in your new sales?
The second question, if you could give us an update on the company initiatives to help enhance the visibility of the quality and the claim of the portfolios that you're offering to operators.
Can you hear me very well? I was talking to the wall. I do apologize for that.
In the growth adds, I cannot comment because it's not stable. We have put all of the contracts and the brokerage until the end of January or February. But we still don't understand how the channel is going to respond to this new model of contracting, and we are making changes.
What are we doing in the company? We had a structure that was one size fits all, in the North, West, East and South. Regardless of the product being premium or not, the channel was compensated in the same way. We have now worked with a [ third ] change in the last 7 months. The commercial team, the commercial managers and the brokers, they have compensation structures for Affinity that will change by type of product, type of operator, early churn, early claims and the use of our service channels.
These were some of the dimensions, and this is still very unstable. We truly don't know what will happen, but we think that we have ascertained in terms of our changes.
Then at the end of the second quarter, if you could please ask that question. Again, I think we will be able to give you a better answer with a better interpretation and to say the mix is 80% Affinity, 20% SME or 60%, 40%.
Sao Paulo Bahia today, we still have a great deal of turbulence with great variations month after month. In some months, we have huge increases in one market, decreases in another, and this points to the fact that it is unstable.
If you could give us an update on the company initiatives to improve the claims among the operator.
I'm sorry, I did forget that second question. In October of last year, we began to rework on the acceptance structures. We saw what was a lot of red tape, was uncomfortable for the client and was not efficient. Nowadays in terms of our acceptance structure, the teams are dealing with this. They have deep knowledge of how acceptance work within an operator.
So we're replicating the structure of the operators and the company. We're working in alignment. We have brought in-house, the main partners, to look at this and to work with a benchmarking to see what are you doing that we're not doing and vice versa, and we have received regular feedback from them. And we see that we're equivalent or were somewhat above in terms of what we thought we were doing.
We have brought in a new middle Technical Director in-house to work with the operator, a seasoned person in group medicine and hospital networks and the team that has come with him has worked a great deal with operators. And obviously, all of this will lead to better claim levels in the short and midterm.
What is the problem with this? We will have more conflict in our sales cycle with the commercial team, and we're trying to resolve this in the flow of acceptance if we're more rigorous in the interview, we're being more relaxed in terms of the interview.
Nowadays, we're working since the end of December, I could be mistaken, but I will confirm with you the right date. We're working with rapid attention interviews. The client can come in any day, any hour to confirm the health conditions that he or she has, and additionally to this, we're giving the client a very quick response in terms of -- which is our response and having a very quick turnaround in terms of the acceptance process. And we will have the confirmation from the regional sector that is interviewing clients as well so that we can reduce our fraud level. And I think operators have looked upon this very positively. And this allows the operator to better understand what we're doing.
Our next question comes from Ricardo Boiati from Safra.
My first question regarding the churn. If you could give us a bit more color of what happened with a client who has canceled the health plan if they're going to a competitor, perhaps in the Affinity segment. If they're still migrating to an SME plan, who is migrating to individual plans, vertical plans? Or if they're uncovered by health plans. If you could add any more information regarding to these cancellations and what happens to the clients, this would help us in working with the company dynamic.
The second question refers to a specific line item in the balance, the premium. I would like to understand if there is a specific reason for the increase in premiums, if you're awaiting a normalization of this line item, if this is due to a typical seasonality in your operation.
The churn, I think, is a portrait of the confusion we see in the retail market that we commented. Clients go one side to the other side or for individual plans. Operators that are offering individual plans for those who are older than 59 years of age have also proven to have a high capacity to attract clients. There is a great deal of confusion.
Now where are clients not going to -- they are not going to competitor products or competitive managers. We have a very broad portfolio in the company and we don't see broad portfolios in the rest of the market. Although our portfolio has shrunk considerably. So they're going to SME as well as to individual operators focused on senior customer.
This is not a stable position. It will change during the year because of everything that we discuss. Now this portrait will not explain what will happen in the rest of the year. Let's wait and see.
Thank you very much, Mauricio. And perhaps Vasques could speak about the premiums that have to be paid or transferred?
The premium are part of the company dynamic and the working capital of the company we collect. We collect the ticket, the collection, there's a management rate and the carryover for the company, and we have the payables at the other end as part of the working capital of the company. Sometime we have some good placements, which can be part of the working capital management. What we do with operators, with beneficiaries, with Gama. It's some of the effect of what we have just said. So we have to cut this and understand each element separately.
We have a strategy for each of these elements because they are relevant, we're speaking about 600 in liabilities. And of course, this requires attention. Now that part is part of the working capital of operators, that line item.
Our next question come from Estela Strano from JPMorgan.
A quick question, which is the approximate duration of our portfolio. I don't know if you can break down this figure, or give us a qualitative viewpoint.
You said there was an increase in the duration of portfolios in this year of restructuring and follow-up of the question of a colleague when we spoke about mix. If you could speak all about mix, type of product, but of segmentation, the entry segment, the intermediate segment and the premium segment?
I'm going to begin here with the first part, which is part of the discussion of churn of our initiative. What we have adopted here is the logic of amortization of CAC. It is being amortized in a period of 30 months. And this is what we're going to work with. We have other products that have a higher turnover. Other products that remain more time. So this plan leads us to that 30-month period.
Thank you, Estela, for the question. Regarding the segmentation, as I mentioned in the previous question, we have found a great deal of volatility in terms of how this is being done. Some operators have volunteered faster in the premium. We have had a relevant reduction of prices in one operator from the middle downward. And in the middle segment, we will have prices aligned with the inflation in our sales portfolio today. I believe that in both cases, we should have somewhat more volume in these categories.
Now when it comes to the basic portfolio, we were holding contract negotiation with a large operator, if there was no result, there would be an increase in the mix of premium. But as we're working with a closed contract, we will once again be able to sell a basic product that has a large scale. I don't think there will be a change in the mix at present.
Our next question comes from Caio Moscardini from Santander.
We have 2 questions at our end. Mauricio mentioned that some operators are open to discussion, offering Quali better commercial conditions. Now have you seen the perception among operators in general? Are they able to perceive the efforts of Quali to increase the sustainability of the product. And if this can translate into better gross sales going forward?
Additionally to this, I would like to understand if this better relationship with operators and efforts to improve the claims of portfolio could lead to an improvement in take rate in the company going forward.
Thank you for the question. Regarding the claims, we have had a great deal of evolution. We have an open door at all of the operators. We have had good technical conversations, very productive conversations. The timing is poor. The market moment is quite complex. I think we have had resounding conversation.
Now in terms of what the operators expect in terms of their production with us, they have the expectation that we will increase the volume of production. We also expect the rate. We have to work with the regauging of the CAC, we have to work with the regauging of commercial teams. In another quarter, we should be able to stabilize how we believe that CAC should be hit.
In my viewpoint, we think that CAC is low, we should work with the CAC with greater efficiency. Now and the conversation with the operators is doing very well. I think that's our answer.
And if the better relationship with the operators and as the claim of portfolios dropped. If this will lead to an increase in take rate for some time already, perhaps 5 years, the operators have ensured that part of the commissions are linked to the results with the product. That dynamic will not change. It is permanent.
We have spoken quite a bit about this. If the claim dropped, we would like to understand how we will be remunerated, but there is no substantial development at present. The conversation exists, but it has not been fully materialized. We're speaking about the portfolio, and we're speaking about sales. We're going to focus on the distribution of products, products that are sustainable in the long-term. And this second conversation will appear naturally, but we're only in the first stage. We haven't gotten to that second stage yet.
Our next question come from Marcio Osako from Bradesco BBI.
Two questions at our end. Recently, you have had the withdrawal of [indiscernible] by some operators and the withdrawal of operators that have gone to the competition. Have you seen this type of movement? And what is happening with the mix of your sales portfolio? When you compare this, you have a base of beneficiaries that no longer have sales at one end, perhaps those figures will decrease because you no longer have the sales.
And the second question which has been the impact on the sales of this more rigorous selection to avoid fraud and higher claim levels. If your rejection of proposals has increased significantly. If you could refer to that, please.
Thank you for the 2 questions. The operator is called [indiscernible]. This is the name they use. You have seen this in the retail market, and the Quali dynamic has participated with this, the operator is sovereign and they will define what to do with their portfolio. At the end of the day, it is the operator who makes this decision.
What we have found in this process is that the operator send something drastic, huge cancellations, a more confusing process. And after we sit down with them and negotiate, trying to favor the client in the technically correct way, the size of the problem will decrease. This has been the dynamic in the last few months. And I think we have done very well, advocating for the clients and advocating for the sector as a whole.
In terms of acceptance, yes, our acceptance is ever more rigorous. We're not convinced that our acceptance process is correct. And it has to be something neutral. The risks have to be included correctly if the person has a temporary coverage. We have to continue to offer them that if the person has no coverage if the health condition does not lead to other risks that are offered in the product, the customer will have to gain coverage.
Now the commercial team is having greater difficulties in placing those products in the brokerage channel. We think that in the retail market, regardless of the product, they will only have sustainability in the long-term if we work correctly with acceptance.
Now having said that, the retail market will never disappear. An operator may withdraw product, operator #2 will offer that kind of product. And people that need a health plan, and health plan is a second or third greatest desire of the population. If there is demand, there will be supply.
And you're looking at it from your side as analysts of the sector, perhaps the more traditional operators have become more restrictive and we have a group of operators that are more aggressive that are coming about the [ incumbent ] will have -- but they also will have difficulty through the new cycles. And these new operators have grown during the last few years. It's part of the retail market, and this is definitely a retail product, and we want to have protagonism in the distribution of all of these products.
It doesn't matter how the retail market has been confirmed. We have the capacity for the distribution and claims decrease, some operators will become more aggressive and sales will increase. I don't have that pessimistic viewpoint that the retail segment products have ended, quite the contrary. There is restriction in traditional products, but there will always be products, and they will work for any retail segment, they can be medical products, consumption products or others.
And in terms of the cleanup, we're struggling with it, making sure that what has to be done, will be done, but we're working to favor the beneficiary.
The question-and-answer session ends here. We would like to turn the floor over to Mauricio Lopes, the company's CEO, for the closing remarks.
I simply wanted to thank you, reinforce the view of the management that all of the levers that have to be changed to carry out the turnaround in the company and to gain protagonism in the retail segment are being used.
And I'm surprised with the execution capacity of our Quali, the devotion of our leaders that are helping us to work with this turnaround with acceptance, the market that is very complex, but with cash, with a better cash situation with the company within a better rightsizing, with everything in place and the ability to recover margins, we will emerge stronger once the curve of the sector is altered. At some point in time, it will be altered we will see a reduction in the volume of complaints that has been quite large with the operators but we will have that ability to gain resilience in this sector.
So I reinforce my commitment with it, and I reinforce the commitment of the Quali team in working in this turnaround. Thank you all once again. Have a good day.
The fourth quarter 2023 earnings results conference call ends here. We would like to thank all of you for your attendance. Have a good afternoon.
[Statements in English on this transcript were spoken by an interpreter present on the live call.]